Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death

Pediatrics

Volumn 117, Issue 1, 2006, Pages 67-74

  Clark, Reese H ^a,b   Bloom, Barry T ^a   Spitzer, Alan R ^a   Gerstmann, Dale R ^a  

^a Pediatrix Obstetrix Center for Research and Education   (United States)

^b PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

Antibiotics; Mortality; Neonate; Sepsis

Indexed keywords

AMPICILLIN; CEFOTAXIME; GENTAMICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DEATH; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; PERINATAL ASPHYXIA; PREMATURITY; PRIORITY JOURNAL; SIDE EFFECT; ANTIBIOTIC PROPHYLAXIS; DRUG COMBINATION; INFANT MORTALITY; RISK FACTOR; SEPSIS;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFOTAXIME; DRUG THERAPY, COMBINATION; GENTAMICINS; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; RISK FACTORS; SEPSIS;

EID: 33644846534     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0179     Document Type: Article

References (14)

1. Alarcon A, Pena P, Salas S, Sancha M, Omenaca F. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J. 2004;23:295-299
2. Luck S, Torny M, d'Agapeyeff K, et al. Estimated early-onset group B streptococcal neonatal disease. Lancet. 2003;361:1953-1954
3. American College of Obstetricians and Gynecologists. ACOG Committee Opinion: number 279, December 2002: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2002;100:1405-1412
4. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347:240-247
5. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics. 1997;99:489-496
6. Baker CJ, Kanto WP Jr. Implementing new GBS guidelines requires coordinated care. AAP News. 2003;22(2):79-86
7. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000;355:973-978
8. Cordero L, Rau R, Taylor D, Ayers LW. Enteric Gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Am J Infect Control. 2004;32:189-195
9. Benjamin DK Jr, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics. 2003;112:543-547
10. Clark R, Powers R, White R, Bloom B, Sanchez P, Benjamin DK Jr. Prevention and treatment of nosocomial sepsis in the NICU. J Perinatol. 2004;24:446-453
11. Benjamin DK, DeLong E, Cotten CM, Garges HP, Steinbach WJ, Clark RH. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol. 2004;24:175-180
12. Benjamin DK Jr, DeLong ER, Cotten CM, Garges HP, Clark RH. Postconception age and other risk factors associated with mortality following Gram-negative rod bacteremia. J Perinatol. 2004;24:169-174
13. Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol. 2004;191:481-487
14. Garite TJ, Clark RH, Elliott JP, Thorp JA. Twins and triplets: the effect of plurality and growth on neonatal outcome compared with singleton infants. Am J Obstet Gynecol. 2004;191:700-707